https://m2.mtmt.hu/ hun 2026-09-20 16:16 JournalArticle 35764303 VALIDATED true 0 false 2026-06-01T06:55:18.644+0000 2025-02-25T12:48:34.632+0000 2025-02-17T09:26:55.780+0000 true 10091267 Sasidharan Shan /api/author/10091267 Author Sasidharan Shan (farmakologia) true 2025-03-18T09:22:03.839+0000 2025-03-18T09:22:03.839+0000 2025-02-25T12:48:34.637+0000 true 10080205 Szalóky-Siki Ágnes /api/admin/10080205 Admin Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) true true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Silambarasan, Rajendran true true /api/journal/10057789 REVIEWED HELIYON 2405-8440 true false 10057789 false 10057789 true 2405-8440 Journal FOREIGN 11 4 e42582 e42582 23 2025 true true 2025 true true true false true false GOLD 2026-06-01 false https://www.cell.com/heliyon/home 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Q1 false false false false 2025-02-24T12:48:34.508+0000 Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); HCEMM- SE Kardiovaszkuláris Komorbiditások Kuta... (SE / AOK / I / FFI) 1 5 2 8 0 false Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 123354004 /api/authorship/123354004 Silambarasan, Rajendran 1 0.125 true false false Silambarasan Rajendran true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123354005 /api/authorship/123354005 Kasthuri Nair, A. 2 0.125 false false false Kasthuri Nair A. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123354006 /api/authorship/123354006 Maniyan, Gomathi 3 0.125 false false false Maniyan Gomathi true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123354007 /api/authorship/123354007 Vijaya, R. 4 0.125 false false false Vijaya R. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123354008 /api/authorship/123354008 Nair, Reshma V.R. 5 0.125 false false false Nair Reshma V.R. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123354009 /api/authorship/123354009 Hareendran Nair, J. 6 0.125 false false false Hareendran Nair J. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123354010 /api/authorship/123354010 Nishanth Kumar, S. 7 0.125 false false false Nishanth Kumar S. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 123354011 /api/authorship/123354011 Sasidharan, Shan ✉ [Sasidharan, Shan (farmakologia), szerző] Farmakológiai és Farmakoterápiás Intézet (SE / AOK / I); HCEMM- SE Kardiovaszkuláris Komorbiditások Kuta... (SE / AOK / I / FFI) 8 0.125 false true true Author 10091267 /api/author/10091267 Sasidharan Shan (farmakologia) Sasidharan Shan true true Sasidharan Shan true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 28411419 /api/publicationidentifier/28411419 DOI: 10.1016/j.heliyon.2025.e42582 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true IDENTICAL 10.1016/j.heliyon.2025.e42582 https://doi.org/10.1016/j.heliyon.2025.e42582 false true PublicationIdentifier 28471637 /api/publicationidentifier/28471637 Scopus: 85217536477 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85217536477 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85217536477 false true Classification 12197 /api/classification/12197 Gyógyszerészet, farmakogenomika, gyógyszerkutatás és tervezés, gyógyszeres kezelés true true SjrRating 11736320 /api/sjrrating/11736320 sjr:Q1 (2025) Scopus - Multidisciplinary HELIYON 2405-8440 35 0.24 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1000 /api/classificationexternal/1000 Scopus - Multidisciplinary true 1000 true Q1 DIRECT true true Reference 63570185 /api/reference/63570185 1. Delara 2012: Health related quality of life among adolescents with premenstrual disorders: a cross sectional study., Health Qual. Life Outcome, 10, p. 1, DOI: 10.1186/1477-7525-10-1 1 10.1186/1477-7525-10-1 false true Reference 63570186 /api/reference/63570186 2. Bari 2009: Abnormal vaginal bleeding correspondence., Gynecology, 17, p. 184 2 false true Reference 63570187 /api/reference/63570187 3. Bhatia 2015: Traditional phytoremedies for the treatment of menstrual disorders in district Udhampur, J& K, India., J. Ethnopharmacol., 160, p. 202, DOI: 10.1016/j.jep.2014.11.041 3 10.1016/j.jep.2014.11.041 false true Reference 63570188 /api/reference/63570188 4. Nloh 2020: Prevalence and factors associated with dysmenorrhea in women at child bearing age in the dschang health district, west-Cameroon., Pan African Med. J., 37, p. 1 4 false true Reference 63570189 /api/reference/63570189 5. Ryu 2015: Premenstrual syndrome: a mini review., Maturitas, 82, p. 436, DOI: 10.1016/j.maturitas.2015.08.010 5 10.1016/j.maturitas.2015.08.010 false true Reference 63570190 /api/reference/63570190 6. https://www.who.int/news/item/28-05-2023-menstrual-health-not-just-hygiene-the-path-toward-a-strong-cross-sectoral-response#:∼:text=Most%20recently%2C%20in%20partnership%20with,promotive%2C%20preventative%20and%20curative%20health, (n.d.). 6 false true Reference 63570191 /api/reference/63570191 7. Schliep 2023: Examining the co-occurrence of endometriosis and polycystic ovarian syndrome., AJOG Global Rep., 3 7 false true Reference 63570192 /api/reference/63570192 8. Kim 2023: The phytochemical constituents of medicinal plants for the treatment of chronic inflammation., Biomolecules, 13, p. 1162, DOI: 10.3390/biom13081162 8 10.3390/biom13081162 false true Reference 63570193 /api/reference/63570193 9. Samani 2018: The prevalence of menstrual disorders in Iran: a systematic review and meta-analysis., Int J Reprod Biomed, 16, p. 665 9 false true Reference 63570194 /api/reference/63570194 10. Armour 2019: The effectiveness of self-care and lifestyle interventions in primary dysmenorrhea: a systematic review and meta-analysis., BMC Compl. Alternative Med., 19, p. 22, DOI: 10.1186/s12906-019-2433-8 10 10.1186/s12906-019-2433-8 false true Reference 63570195 /api/reference/63570195 11. Neina 2021: Ecological and edaphic drivers of yam production in west africa., Appl Environ Soil Sci, 2021, p. 1, DOI: 10.1155/2021/5019481 11 10.1155/2021/5019481 false true Reference 63570196 /api/reference/63570196 12. Dumont 2000: Domestication of yams (Dioscorea cayenensis-rotundata) within the bariba ethnic group in Benin., Outlook Agric., 29, p. 137, DOI: 10.5367/000000000101293149 12 10.5367/000000000101293149 false true Reference 63570197 /api/reference/63570197 13. Chaturvedi 2007: Cloning of medicinal plants through tissue culture-A review., Indian J. Exp. Biol., 45, p. 937 13 false true Reference 63570198 /api/reference/63570198 14. Dutta 2015: Food and medicinal values of certain species of Dioscorea with special reference to Assam., J. Pharmacogn. Phytochem., 3, p. 15 14 false true Reference 63570199 /api/reference/63570199 15. Lebot 2023: The greater yam (Dioscorea alata L.): a review of its phytochemical content and potential for processed products and biofortification., J. Food Compos. Anal., 115, DOI: 10.1016/j.jfca.2022.104987 15 10.1016/j.jfca.2022.104987 false true Reference 63570200 /api/reference/63570200 16. Mulualem 2018: Genetic diversity of yam (Dioscorea spp.) landrace collections from Ethiopia using simple sequence repeat markers., Aust. J. Crop. Sci., 12, p. 1222, DOI: 10.21475/ajcs.18.12.08.PNE885 16 10.21475/ajcs.18.12.08.PNE885 false true Reference 63570201 /api/reference/63570201 17. Salehi 2019: Dioscorea plants: a genus rich in vital nutra-pharmaceuticals-A review., Iran. J. Pharm. Res. (IJPR), 18, p. 68 17 false true Reference 63570202 /api/reference/63570202 18. Hsu 2011: The assessment of efficacy of Diascorea alata for menopausal symptom treatment in Taiwanese women., Climacteric, 14, p. 132, DOI: 10.3109/13697137.2010.498594 18 10.3109/13697137.2010.498594 false true Reference 63570203 /api/reference/63570203 19. Sethi 2018: Pro-apoptotic and anti-cancer properties of diosgenin: a comprehensive and critical review., Nutrients, 10, DOI: 10.3390/nu10050645 19 10.3390/nu10050645 false true Reference 63570204 /api/reference/63570204 20. Cai 2020: Therapeutic potential of diosgenin and its major derivatives against neurological diseases: recent advances., Oxid. Med. Cell. Longev., 2020, DOI: 10.1155/2020/3153082 20 10.1155/2020/3153082 false true Reference 63570205 /api/reference/63570205 21. Grandi 2023: Phyto-progestins for the treatment of abnormal uterine bleeding without organic cause in women at high risk for breast cancer and breast cancer survivors: a prospective, pilot study., Gynecol. Endocrinol., 39, DOI: 10.1080/09513590.2023.2239936 21 10.1080/09513590.2023.2239936 false true Reference 63570206 /api/reference/63570206 22. Alshehri 2021: Therapeutic potential of isoflavones with an emphasis on daidzein., Oxid. Med. Cell. Longev., 2021, DOI: 10.1155/2021/6331630 22 10.1155/2021/6331630 false true Reference 63570207 /api/reference/63570207 23. Thangavel 2019: Genistein as potential therapeutic candidate for menopausal symptoms and other related diseases., Molecules, 24, p. 1, DOI: 10.3390/molecules24213892 23 10.3390/molecules24213892 false true Reference 63570208 /api/reference/63570208 24. Arcoraci 2017: Antiosteoporotic activity of genistein aglycone in postmenopausal women: evidence from a post-hoc analysis of a multicenter randomized controlled trial., Nutrients, 9, DOI: 10.3390/nu9020179 24 10.3390/nu9020179 false true Reference 63570209 /api/reference/63570209 25. Kenda 2021: Herbal products used in menopause and for gynecological disorders., Molecules, 26, p. 7421, DOI: 10.3390/molecules26247421 25 10.3390/molecules26247421 false true Reference 63570210 /api/reference/63570210 26. Adomėnienė 2022: Dioscorea spp.: comprehensive review of antioxidant properties and their relation to phytochemicals and health benefits., Molecules, 27, DOI: 10.3390/molecules27082530 26 10.3390/molecules27082530 false true Reference 63570211 /api/reference/63570211 27. Wang 2023: Dioscorea spp.: bioactive compounds and potential for the treatment of inflammatory and metabolic diseases., Molecules, 28, p. 2878, DOI: 10.3390/molecules28062878 27 10.3390/molecules28062878 false true Reference 63570212 /api/reference/63570212 28. Padhan 2020: Potential of neglected and underutilized yams (Dioscorea spp.) for improving nutritional security and health benefits., Front. Pharmacol., 11, DOI: 10.3389/fphar.2020.00496 28 10.3389/fphar.2020.00496 false true Reference 63570213 /api/reference/63570213 29. Zheng 2022: Application of network pharmacology in the study of mechanism of Chinese medicine in the treatment of ulcerative colitis: a review., Front. Bioinform., 2, p. 1, DOI: 10.3389/fbinf.2022.928116 29 10.3389/fbinf.2022.928116 false true Reference 63570214 /api/reference/63570214 30. Wang 2021: Deep learning in systems medicine., Briefings Bioinf., 22, p. 1543, DOI: 10.1093/bib/bbaa237 30 10.1093/bib/bbaa237 false true Reference 63570215 /api/reference/63570215 31. Li 2021: Network pharmacology-based approach to investigate the molecular targets of sinomenine for treating breast cancer., Cancer Manag. Res., 13, p. 1189, DOI: 10.2147/CMAR.S282684 31 10.2147/CMAR.S282684 false true Reference 63570216 /api/reference/63570216 32. Niu 2021: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6., Biosci. Rep., 41, p. 1, DOI: 10.1042/BSR20202583 32 10.1042/BSR20202583 false true Reference 63570217 /api/reference/63570217 33. Zuo 2018: Integrating network pharmacology and metabolomics study on anti-rheumatic mechanisms and antagonistic effects against methotrexate-induced toxicity of qing-Luo-yin., Front. Pharmacol., 9, p. 1, DOI: 10.3389/fphar.2018.01472 33 10.3389/fphar.2018.01472 false true Reference 63570218 /api/reference/63570218 34. Srikanth 2021: Bioinformatics and network pharmacology: scope and relevance in Ayurveda research., J Drug Res Ayurvedic Sci, 6, p. 197, DOI: 10.4103/jdras.jdras_28_22 34 10.4103/jdras.jdras_28_22 false true Reference 63570219 /api/reference/63570219 35. Choudhary 2022: Multi-scale mechanism of antiviral drug-alike phytoligands from Ayurveda in managing COVID-19 and associated metabolic comorbidities: insights from network pharmacology., Mol. Divers., 26, p. 2575, DOI: 10.1007/s11030-021-10352-x 35 10.1007/s11030-021-10352-x false true Reference 63570220 /api/reference/63570220 36. Li 2021: Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer., Sci. Rep., 11, p. 1 36 false true Reference 63570221 /api/reference/63570221 37. Deng 2023: A novel strategy for active compound efficacy status identification in multi-tropism Chinese herbal medicine (Scutellaria baicalensis Georgi) based on multi-indexes spectrum-effect gray correlation analysis., J. Ethnopharmacol., 300, DOI: 10.1016/j.jep.2022.115677 37 10.1016/j.jep.2022.115677 false true Reference 63570222 /api/reference/63570222 38. PubChem, (n.d.). https://pubchem.ncbi.nlm.nih.gov/(accessed October 5, 2024). 38 false true Reference 63570223 /api/reference/63570223 39. Yu 2017: A systems pharmacology approach to determine active compounds and action mechanisms of xipayi KuiJie’an enema for treatment of ulcerative colitis., Sci. Rep., 7, p. 1 39 false true Reference 63570224 /api/reference/63570224 40. pkCSM, (n.d.). https://biosig.lab.uq.edu.au/pkcsm/(accessed October 5, 2024). 40 false true Reference 63570225 /api/reference/63570225 41. Ahamad 2023: Identification of novel tau-tubulin kinase 2 inhibitors using computational approaches., ACS Omega, 8, p. 13026, DOI: 10.1021/acsomega.3c00225 41 10.1021/acsomega.3c00225 false true Reference 63570226 /api/reference/63570226 42. Binding Database, (n.d.). https://www.bindingdb.org/bind/index_original.jsp (accessed October 5, 2024). 42 false true Reference 63570227 /api/reference/63570227 43. ChEMBL Database, (n.d.). https://www.ebi.ac.uk/chembl/(accessed October 5, 2024). 43 false true Reference 63570228 /api/reference/63570228 44. SwissTargetPrediction, (n.d.). http://swisstargetprediction.ch/(accessed October 5, 2024). 44 false true Reference 63570229 /api/reference/63570229 45. UniProt, (n.d.). https://www.uniprot.org/(accessed October 5, 2024). 45 false true Reference 63570230 /api/reference/63570230 46. Law 2014: DrugBank 4.0: shedding new light on drug metabolism., Nucleic Acids Res., 42, p. D1091, DOI: 10.1093/nar/gkt1068 46 10.1093/nar/gkt1068 false true Reference 63570231 /api/reference/63570231 47. STRING: functional protein association networks, (n.d.). https://string-db.org/(accessed October 5, 2024). 47 false true Reference 63570232 /api/reference/63570232 48. Szklarczyk 2017: The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible., Nucleic Acids Res., 45, p. D362, DOI: 10.1093/nar/gkw937 48 10.1093/nar/gkw937 false true Reference 63570233 /api/reference/63570233 49. SPEED2, (n.d.). https://speed2.sys-bio.net/(accessed October 5, 2024). 49 false true Reference 63570234 /api/reference/63570234 50. Rydenfelt 2020: SPEED2: inferring upstream pathway activity from differential gene expression., Nucleic Acids Res., 48, p. W307, DOI: 10.1093/nar/gkaa236 50 10.1093/nar/gkaa236 false true Reference 63570235 /api/reference/63570235 51. Trott 2010: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading., J. Comput. Chem., 31, p. 455, DOI: 10.1002/jcc.21334 51 10.1002/jcc.21334 false true Reference 63570236 /api/reference/63570236 52. AutoDock, (n.d.). https://autodock.scripps.edu/(accessed October 5, 2024). 52 false true Reference 63570237 /api/reference/63570237 53. Varadi 2020: PDBe-KB: a community-driven resource for structural and functional annotations., Nucleic Acids Res., 48, p. D344, DOI: 10.1093/nar/gkz853 53 10.1093/nar/gkz853 false true Reference 63570238 /api/reference/63570238 54. RCSB PDB: Homepage, (n.d.). https://www.rcsb.org/(accessed October 5, 2024). 54 false true Reference 63570239 /api/reference/63570239 55. Dinparast 2020: An efficient, catalyst-free, one-pot synthesis of 4H-chromene derivatives and investigating their biological activities and mode of interactions using molecular docking studies., J. Mol. Struct., 1203, DOI: 10.1016/j.molstruc.2019.127426 55 10.1016/j.molstruc.2019.127426 false true Reference 63570240 /api/reference/63570240 56. Kazama 2015: Prevalence of dysmenorrhea and its correlating lifestyle factors in Japanese female junior high school students., Tohoku J. Exp. Med., 236, p. 107, DOI: 10.1620/tjem.236.107 56 10.1620/tjem.236.107 false true Reference 63570241 /api/reference/63570241 57. Zhang 2023: Multi-component Chinese medicine formulas for drug discovery: state of the art and future perspectives., Acta Materia Medica, 2, p. 106, DOI: 10.15212/AMM-2022-0049 57 10.15212/AMM-2022-0049 false true Reference 63570242 /api/reference/63570242 58. Amabie 58 false true Reference 63570243 /api/reference/63570243 59. Chandramouli 2021: Phytomolecules repurposed as covid-19 inhibitors: opportunity and challenges., Curr. Microbiol., 78, p. 3620, DOI: 10.1007/s00284-021-02639-x 59 10.1007/s00284-021-02639-x false true Reference 63570244 /api/reference/63570244 60. Li 2023: Network pharmacology: a bright guiding light on the way to explore the personalized precise medication of traditional Chinese medicine., Chin. Med., 18, p. 1, DOI: 10.1186/s13020-023-00853-2 60 10.1186/s13020-023-00853-2 false true Reference 63570245 /api/reference/63570245 61. Noor 2022: Network pharmacology approach for medicinal plants: review and assessment., Pharmaceuticals, 15, p. 572, DOI: 10.3390/ph15050572 61 10.3390/ph15050572 false true Reference 63570246 /api/reference/63570246 62. Obidiegwu 2020: The Dioscorea genus (Yam)—an appraisal of nutritional and therapeutic potentials., Foods, 9, p. 1304, DOI: 10.3390/foods9091304 62 10.3390/foods9091304 false true Reference 63570247 /api/reference/63570247 63. Cheng 2007: Isolation and identification of novel estrogenic compounds in yam tuber (Dioscorea alata cv. Tainung No. 2)., J. Agric. Food Chem., 55, p. 7350, DOI: 10.1021/jf0711690 63 10.1021/jf0711690 false true Reference 63570248 /api/reference/63570248 64. Faiyaz Ahmed Faiyaz Ahmed 2009: Total phenolic content and antioxidant activity of aqueous and methanol extracts of Dioscorea alata tuber., J. Pharm. Res., 2, p. 1663 64 false true Reference 63570249 /api/reference/63570249 65. Maithili 2011: Antidiabetic activity of ethanolic extract of tubers of Dioscorea alata in alloxan induced diabetic rats., Indian J. Pharmacol., 43, p. 455, DOI: 10.4103/0253-7613.83121 65 10.4103/0253-7613.83121 false true Reference 63570250 /api/reference/63570250 66. Makiyah 2022: Dioscorea alata L. Tubers improve diabetes through anti-hyperglycemia, anti-inflammation, ameliorate insulin resistance and mitochondrial dysfunction., Indonesian Biomed. J., 14, p. 365, DOI: 10.18585/inabj.v14i4.1966 66 10.18585/inabj.v14i4.1966 false true Reference 63570251 /api/reference/63570251 67. Itriyeva 2022: The effects of obesity on the menstrual cycle., Curr. Probl. Pediatr. Adolesc. Health Care, 52 67 false true Reference 63570252 /api/reference/63570252 68. Rani 2023: Network pharmacology and molecular docking study of the active ingredients in Saptasaram kashayam for the treatment of Polycystic ovary syndrome., Indian J. Biochem. Biophys., 60, p. 108 68 false true Reference 63570253 /api/reference/63570253 69. Li 2020: Dissecting the mechanism of Yuzhi Zhixue granule on ovulatory dysfunctional uterine bleeding by network pharmacology and molecular docking., Chin. Med., 15, p. 113, DOI: 10.1186/s13020-020-00392-0 69 10.1186/s13020-020-00392-0 false true Reference 63570254 /api/reference/63570254 70. Shahzad 2015: Quercetin induces dose-dependent differential morphological and proliferative changes in rat uteri in the presence and in the absence of estrogen., J. Med. Food, 18, p. 1307, DOI: 10.1089/jmf.2014.3293 70 10.1089/jmf.2014.3293 false true Reference 63570255 /api/reference/63570255 71. Higuchi 2023: Effect of γ-tocopherol supplementation on premenstrual symptoms and natriuresis: a randomized, double-blind, placebo-controlled study., BMC Complement Med Ther, 23, DOI: 10.1186/s12906-023-03962-5 71 10.1186/s12906-023-03962-5 false true Reference 63570256 /api/reference/63570256 72. Baniadam 2014: Cycloartane Triterpenoids from Euphorbia Macrostegia with Their Cytotoxicity against MDA-MB48 and MCF-7 Cancer Cell Lines 72 false true Reference 63570257 /api/reference/63570257 73. McDonald 2006: 11β-Hydroxysteroid dehydrogenases in human endometrium., Mol. Cell. Endocrinol., 248, p. 72, DOI: 10.1016/j.mce.2005.12.010 73 10.1016/j.mce.2005.12.010 false true Reference 63570258 /api/reference/63570258 74. Xie 2023: Chitosan oligosaccharide improves ovarian granulosa cells inflammation and oxidative stress in patients with polycystic ovary syndrome., Front. Immunol., 14, DOI: 10.3389/fimmu.2023.1086232 74 10.3389/fimmu.2023.1086232 false true Reference 63570259 /api/reference/63570259 75. Khezri 2021: Genistein blunted detrimental effects of polycystic ovary syndrome on the ovarian tissue of rats by improving follicular development and gonadotropin secretion., JBRA Assist Reprod, DOI: 10.5935/1518-0557.20210089 75 10.5935/1518-0557.20210089 false true Reference 63570260 /api/reference/63570260 76. Guo 2014: Genistein modulation of streptozotocin diabetes in male B6C3F1 mice can be induced by diet., Toxicol. Appl. Pharmacol., 280, p. 455, DOI: 10.1016/j.taap.2014.08.028 76 10.1016/j.taap.2014.08.028 false true Reference 63570261 /api/reference/63570261 77. El-Kordy 2015: Effect of genistein, a natural soy isoflavone, on pancreatic β-cells of streptozotocin-induced diabetic rats: histological and immunohistochemical study., J Microsc Ultrastruct, 3, p. 108, DOI: 10.1016/j.jmau.2015.03.005 77 10.1016/j.jmau.2015.03.005 false true Reference 63570262 /api/reference/63570262 78. Liu 2017: The effect of genistein on glucose control and insulin sensitivity in postmenopausal women: a meta-analysis., Maturitas, 97, p. 44, DOI: 10.1016/j.maturitas.2016.12.004 78 10.1016/j.maturitas.2016.12.004 false true Reference 63570263 /api/reference/63570263 79. Xu 2021: Estrogen receptors in polycystic ovary syndrome., Cells, 10, p. 459, DOI: 10.3390/cells10020459 79 10.3390/cells10020459 false true Reference 63570264 /api/reference/63570264 80. Rymbai 2023: The identification of cianidanol as a selective estrogen receptor beta agonist and evaluation of its neuroprotective effects on Parkinson's disease models., Life Sci., 333, DOI: 10.1016/j.lfs.2023.122144 80 10.1016/j.lfs.2023.122144 false true Reference 63570265 /api/reference/63570265 81. Si 2020: Dietary epicatechin, A novel anti-aging bioactive small molecule., Curr. Med. Chem., 28, p. 3, DOI: 10.2174/0929867327666191230104958 81 10.2174/0929867327666191230104958 false true Reference 63570266 /api/reference/63570266 82. Nouri 2017: The impact of a standardized oral multinutrient supplementation on embryo quality in in vitro fertilization/intracytoplasmic sperm injection: a prospective randomized trial., Gynecol. Obstet. Invest., 82, p. 8, DOI: 10.1159/000452662 82 10.1159/000452662 false true Reference 63570267 /api/reference/63570267 83. Shen 2017: Observation of the influences of diosgenin on aging ovarian reserve and function in a mouse model., Eur. J. Med. Res., 22, p. 42, DOI: 10.1186/s40001-017-0285-6 83 10.1186/s40001-017-0285-6 false true Reference 63570268 /api/reference/63570268 84. Luo 2011: Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway., Food Chem., 128, p. 513, DOI: 10.1016/j.foodchem.2011.03.073 84 10.1016/j.foodchem.2011.03.073 false true Reference 63570269 /api/reference/63570269 85. Bergsten 2023: Kaempferol, a phytoprogestin, induces a subset of progesterone-regulated genes in the uterus., Nutrients, 15, p. 1407, DOI: 10.3390/nu15061407 85 10.3390/nu15061407 false true Reference 63570270 /api/reference/63570270 86. Zhou 2015: Protective effects of kaempferol against myocardial ischemia/reperfusion injury in isolated rat heart via antioxidant activity and inhibition of glycogen synthase kinase-3 &lt;math id="M1"&gt; &lt;mrow&gt; &lt;mi mathvariant="italic"&gt;β&lt;/mi&gt; &lt;/mrow&gt; &lt;/math&gt;., Oxid. Med. Cell. Longev., p. 1 86 false true Reference 63570271 /api/reference/63570271 87. Dhar 2024: Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment., Sci. Rep., 14, DOI: 10.1038/s41598-024-75719-0 87 10.1038/s41598-024-75719-0 false true Reference 63570272 /api/reference/63570272 88. Maclean 2022: Progesterone actions and resistance in gynecological disorders., Cells, 11, DOI: 10.3390/cells11040647 88 10.3390/cells11040647 false true Reference 63570273 /api/reference/63570273 89. Yu 2022: Continuous vaginal bleeding induced by EGFR-TKI in premenopausal female patients with EGFR mutant NSCLC., Front. Oncol., 12 89 false true Reference 63570274 /api/reference/63570274 90. Yao 2024: NK-92 cells activated by IL-2 inhibit the progression of endometriosis in vitro., J. Obstet. Gynaecol., 44, DOI: 10.1080/01443615.2024.2372682 90 10.1080/01443615.2024.2372682 false true Reference 63570275 /api/reference/63570275 91. P Trzonkowski, J Mysliwska, Luteal Phase of the Menstrual Cycle in Young Healthy Women Is Associated with Decline in Interleukin 2 Levels, (n.d.). 91 false true Reference 63570276 /api/reference/63570276 92. Hiraoka 2020: Differential roles of uterine epithelial and stromal STAT3 coordinate uterine receptivity and embryo attachment., Sci. Rep., 10, DOI: 10.1038/s41598-020-72640-0 92 10.1038/s41598-020-72640-0 false true Reference 63570277 /api/reference/63570277 93. M.D. Graubert, M.A. Ortega, B. Kessel, J.F. Mortola, M. Luisa Iruela-Arispe, Vascular Repair after Menstruation Involves Regulation of Vascular Endothelial Growth Factor-Receptor Phosphorylation by sFLT-1, n.d. 93 false true Reference 63570278 /api/reference/63570278 94. Irwin 1996 94 false true Reference 63570279 /api/reference/63570279 95. Colón-Díaz 2012: HDAC1 and HDAC2 are differentially expressed in endometriosis., Reprod. Sci., 19, p. 483, DOI: 10.1177/1933719111432870 95 10.1177/1933719111432870 false true Reference 63570280 /api/reference/63570280 96. Long 2006: Polymorphisms of the CYP1B1 gene may be associated with the onset of natural menopause in Chinese women., Maturitas, p. 238, DOI: 10.1016/j.maturitas.2006.03.005 96 10.1016/j.maturitas.2006.03.005 false true Reference 63570281 /api/reference/63570281 97. Liu 2022: Oxytocin in women's health and disease., Front. Endocrinol., 13 97 false true Reference 63570282 /api/reference/63570282 98. Krol 2020: Epigenetic dynamics of the oxytocin receptor gene across the menstrual cycle., Biol. Psychiatry, 87, p. 391, DOI: 10.1016/j.biopsych.2020.02.1000 98 10.1016/j.biopsych.2020.02.1000 false true Reference 63570283 /api/reference/63570283 99. Ellen Pavone 2011: Endometriosis expresses a molecular pattern consistent with decreased retinoid uptake, metabolism and action., Hum. Reprod., 26, p. 2157, DOI: 10.1093/humrep/der172 99 10.1093/humrep/der172 false true Reference 63570284 /api/reference/63570284 100. Liang 2020: Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity — a preliminary report., Can. J. Physiol. Pharmacol., 98, p. 803, DOI: 10.1139/cjpp-2019-0413 100 10.1139/cjpp-2019-0413 false true Reference 63570285 /api/reference/63570285 101. Popova 2019: Not only estradiol but also testosterone levels depend on menstrual cycle phases., Inter Collegas, 6, DOI: 10.35339/ic.6.3.155-161 101 10.35339/ic.6.3.155-161 false true Reference 63570286 /api/reference/63570286 102. Ma 2013: Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: a case-control study., PLoS One, 8 102 false true Reference 63570287 /api/reference/63570287 103. Komesaroff 2001: Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women., Climacteric, 4, p. 144, DOI: 10.1080/cmt.4.2.144.150 103 10.1080/cmt.4.2.144.150 false true Reference 63570288 /api/reference/63570288 104. Zhao 2016: Role of PPAR& gamma; in the nutritional and pharmacological actions of carotenoids., Res. Rep. Biochem., 13 104 false true Reference 63570289 /api/reference/63570289 105. Chung 2000: Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κb., J. Biol. Chem., 275, p. 32681, DOI: 10.1074/jbc.M002577200 105 10.1074/jbc.M002577200 false true Reference 63570290 /api/reference/63570290 106. Liu 2019: Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells., Nat. Commun., 10, p. 4589, DOI: 10.1038/s41467-019-12332-0 106 10.1038/s41467-019-12332-0 false true Reference 63570291 /api/reference/63570291 107. Huang 2008: The role of peroxisome proliferator‐activated receptors in the development and physiology of gametes and preimplantation embryos., PPAR Res., 2008, DOI: 10.1155/2008/732303 107 10.1155/2008/732303 false true Reference 63570292 /api/reference/63570292 108. Velez 2013: The biology of the peroxisome proliferator-activated receptor system in the female reproductive tract., Curr. Pharm. Des., 19, p. 4641, DOI: 10.2174/1381612811319250010 108 10.2174/1381612811319250010 false true Reference 63570293 /api/reference/63570293 109. Vitti 2016: Peroxisome proliferator-activated receptors in female reproduction and fertility., PPAR Res., 2016, p. 1, DOI: 10.1155/2016/4612306 109 10.1155/2016/4612306 false true Reference 63570294 /api/reference/63570294 110. Tabibzadeh 1995: Physiology: site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNFα in human endometrium., Hum. Reprod., 10, p. 277, DOI: 10.1093/oxfordjournals.humrep.a135928 110 10.1093/oxfordjournals.humrep.a135928 false true Reference 63570295 /api/reference/63570295 111. Ciebiera 2018: The role of tumor necrosis factor α in the biology of uterine fibroids and the related symptoms., Int. J. Mol. Sci., 19, p. 3869, DOI: 10.3390/ijms19123869 111 10.3390/ijms19123869 false true Reference 63570296 /api/reference/63570296 112. Haider 2009: Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium., Placenta, 30, p. 111, DOI: 10.1016/j.placenta.2008.10.012 112 10.1016/j.placenta.2008.10.012 false true Reference 63570297 /api/reference/63570297 113. Huo 2007: Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene., Biol. Psychiatry, 62, p. 925, DOI: 10.1016/j.biopsych.2006.12.019 113 10.1016/j.biopsych.2006.12.019 false true Reference 63570298 /api/reference/63570298 114. Muccee 2024: Exploring the association of ESR1 and ESR2 gene SNPs with polycystic ovary syndrome in human females: a comprehensive association study., J. Ovarian Res., 17, p. 27, DOI: 10.1186/s13048-023-01335-7 114 10.1186/s13048-023-01335-7 false true Reference 63570299 /api/reference/63570299 115. Ahamad 2021: A molecular journey to check the conformational dynamics of tau tubulin kinase 2 mutations associated with Alzheimer's disease., RSC Adv., 11, p. 1320, DOI: 10.1039/D0RA07659G 115 10.1039/D0RA07659G false true Reference 63570300 /api/reference/63570300 116. Ahamad 2021: The structural, functional, and dynamic effect of Tau tubulin kinase1 upon a mutation: a neuro-degenerative hotspot., J. Cell. Biochem., 122, p. 1653, DOI: 10.1002/jcb.30112 116 10.1002/jcb.30112 false true Reference 63570301 /api/reference/63570301 117. Ozsoy 2016: The evaluation of IL6 and ESR1 gene polymorphisms in primary dysmenorrhea., Immunol. Investig., 45, p. 75, DOI: 10.3109/08820139.2015.1113426 117 10.3109/08820139.2015.1113426 false true Reference 63570302 /api/reference/63570302 118. Steelman 2008: Akt as a therapeutic target in cancer., Expert Opin. Ther. Targets, 12, p. 1139, DOI: 10.1517/14728222.12.9.1139 118 10.1517/14728222.12.9.1139 false true Reference 63570303 /api/reference/63570303 119. Makker 2014: PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update., J. Mol. Endocrinol., 53, p. R103, DOI: 10.1530/JME-14-0220 119 10.1530/JME-14-0220 false true Reference 63570304 /api/reference/63570304 120. Pant 2012: Inhibition of AKT with the orally active allosteric AKT inhibitor, MK-2206, sensitizes endometrial cancer cells to progestin., PLoS One, 7, DOI: 10.1371/journal.pone.0041593 120 10.1371/journal.pone.0041593 false true Reference 63570305 /api/reference/63570305 121. Merkin 2016: Environmental determinants of polycystic ovary syndrome., Fertil. Steril., 106, p. 16, DOI: 10.1016/j.fertnstert.2016.05.011 121 10.1016/j.fertnstert.2016.05.011 false true /api/publication/35764303 Silambarasan Rajendran et al. Exploring the molecular mechanism of Dioscorea alata L. for the treatment of menstrual disorders using network pharmacology and molecular docking. (2025) HELIYON 2405-8440 11 4<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <div class="autype autype0"> <span class="author-name" >Silambarasan Rajendran </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Kasthuri Nair A. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Maniyan Gomathi </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Vijaya R. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Nair Reshma V.R. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Hareendran Nair J. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" >Nishanth Kumar S. </span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10091267"><a href="/gui2/?type=authors&mode=browse&sel=10091267" target="_blank">Sasidharan Shan ✉ (<span class="authorship-author-name">Sasidharan Shan</span> <span class="authorAux-mtmt"> farmakologia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Farmakológiai és Farmakoterápiás Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/<span title="Farmakológiai és Farmakoterápiás Intézet">FFI</span>/HCEMM- SE Kardiovaszkuláris Komorbiditások Kutatócsoport</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;35764303" target="_blank">Exploring the molecular mechanism of Dioscorea alata L. for the treatment of menstrual disorders using network pharmacology and molecular docking</a></div> <div> <span class="journal-title">HELIYON</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2405-8440">2405-8440</a>)</span>: <span class="journal-volume">11</span> <span class="journal-issue">4</span> <span class="page"> Paper e42582. 23 p. </span> <span class="year">(2025)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="10.1016/j.heliyon.2025.e42582" target="_blank" href="https://doi.org/10.1016/j.heliyon.2025.e42582"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85217536477" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85217536477"> Scopus </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Multidisciplinary&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> </div></OnlyViewableByAuthor> <div class="mtid"><span class="long-pub-mtid">Közlemény: 35764303</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2025.02.25. 13:48 Szalóky-Siki Ágnes (SE_KK_Admin5_SZSA, admin) </div> </div></div>